Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
04 mars 2021 07h00 HE
|
Wave Life Sciences USA, Inc.
Strong execution in 2020 sets stage for advancing five clinical programs and novel ADAR editing modality in 2021 Data from ongoing PRECISION-HD and OLE clinical trials for Huntington’s disease...
Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
26 févr. 2021 09h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides additional study details for...
Global $13.78 Billion Virtual Clinical Trials Markets, 2016-2019 & 2020-2027 by Design, Indication, Phases, Regions & Segment Forecast
25 févr. 2021 08h53 HE
|
Research and Markets
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design; By Indication; By Phases; By Regions; Segment Forecast,...
Insights on the BCL-2 (B Cell Lymphoma 2) Inhibitors Global Market to 2025 - Players Include Abbvie, Amgen and Novartis Among Others
25 févr. 2021 05h28 HE
|
Research and Markets
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering. ...
vTv Therapeutics Announces 2020 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
24 févr. 2021 16h30 HE
|
vTv Therapeutics Inc.
Initiation of Mechanistic Study of TTP399 expected during Q1 2021 Announcement of First-Patient First-Visit in Multiple Ascending Dose Phase 1 Study of HPP737 Publication of Phase 2 SimpliciT-1...
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
24 févr. 2021 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a...
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
24 févr. 2021 06h04 HE
|
PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
Worldwide BiTE Antibodies Industry to 2025 - Players Include Amgen, Bayers & Micromet Among Others
23 févr. 2021 05h38 HE
|
Research and Markets
Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering. This...
Axiom Presents “Innovating Direct-to-Patient Trials: How to use effective eClinical Solutions to enhance the success of your clinical studies” at Outsourcing in Clinical Trials West Coast 2021
22 févr. 2021 12h23 HE
|
Axiom Real-Time Metrics Inc
SAN FRANCISCO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations...
US Alzheimer's Disease Drug Market Clinical Trials Insight 2026 - Clinical Insight on 200 Alzheimer's Disease Drug in Pipeline
22 févr. 2021 04h28 HE
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "US Alzheimer's Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. US...